Biohub
(https://biohub.org) 📸 Data Snapshot: May 26, 2026
Information Density — The Lens
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Info Density
Power-words vs. Substance ratio.
23
Impact Weight: 30 / 100
77% Reputation
The site exhibits high substance, particularly on the AI Models and Research pages, which name specific tools like ESM3 and CELLxGENE. While the homepage H1 ‘Our mission is to cure or prevent all disease’ is a high-altitude power statement, it is immediately supported by the mention of a $500 million commitment and specific research initiatives. Fluff is largely confined to call-to-action headings like ‘Join us in our mission’ and ‘Sign up for our newsletter’.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://biohub.org) Biohub – Leading the new era of AI-powered biology
[H1] Our mission is to cure or prevent all disease At Biohub, we build the technology to help scientists around the world use AI-powered biology to study how cells operate, organize, and work as part of systems to understand why disease happens and how to correct it. With unprecedented scale of compute, AI research and engineering, and state-of-the-art technology for measuring, imaging, and programming biology, Biohub is leading the first large-scale scientific initiative combining frontier AI with frontier biology. [H2] Biohub launches the Virtual Biology Initiative The landmark initiative will galvanize a global effort of leading institutions and consortia to create the technologies and multi-modal datasets needed to build predictive models of the human cell to accelerate the cure and prevention of all disease. Learn more Pause / Play [H2] AI models for scientists and researchers We’re building frontier artificial intelligence for biology, trained on our vast and unique biological datasets, to better predict how human cells behave and how they can change. Scientists will use these models to craft new theories, design powerful experiments, and make breakthrough discoveries about human health and disease. The results will feed back into the AI models, improving their predictive ability — ultimately making it possible to solve disease. [H2] Frontier research to expand scientific knowledge The last decade of genomics and molecular research has generated significant insights into complex biological processes, but limits in technology and the sparsity of data in biology have hindered the application of AI. Our high-throughput data generation engines and discovery platforms will break through these barriers to help us answer some of the most complex questions in human biology. [H3] Dimensional imaging to measure, map, and model complex biological systems We’re building imaging tools that capture life across scales — from single proteins to whole organisms — revealing how cells function, communicate, and assemble into living systems. These observations are laying the groundwork for a new generation of AI models that can predict cellular behavior and guide the development of better treatments for widespread diseases. Learn more [H3] Decoding inflammation to advance human health Inflammation drives the most significant causes of death worldwide. We’re building tools to enable precise molecular-level measurements of inflammation within human tissues in real time, and developing proactive, early interventions that can be deployed when inflammation first flares in the body. Learn more [H3] Programming the immune system for early detection of disease We’re developing AI models and engineered cells that harness our own immune cells to detect and ultimately treat early signs of age-related diseases, like cancer, Alzheimer’s, and Parkinson’s, by delivering targeted treatment only when and where it is needed. Learn more [H2] News See how Biohub is accelerating science research with AI. Read news [H2] Join us in our mission We are a collaborative team of scientists, engineers, and AI and machine learning experts across multiple fields who are passionate about tackling complex challenges and share a unified vision of a world without disease. [IMG: Researcher assembling scientific instruments and electronic components for bioengineering and medical research] Skip to job listings [H3] Apply No openings right now — check back soon. Open positions View all
3544 chars
SUB-PAGE (https://biohub.org/news/) News, blog and press about AI-powered biology – Biohub
[H1] News April 29, 2026 [H2] Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology A $500 million commitment — and a call for the global scientific community to join — aims to unlock predictive models of the human cell to accelerate the cure and prevention of all disease. Read more Filter 415 Results [H2] Filter Close May 18, 2026 [H2] Biology’s blind spot Inflammation drives nearly every major disease, yet we’ve never been able to directly watch it progress in living tissue. These researchers are building the technologies to change that. Blog May 13, 2026 [H2] The immune cell engineers Fifteen research teams are building the molecular toolkit to reprogram the body’s own defenders across diverse disease areas. Blog April 29, 2026 [H2] Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology A $500 million commitment — and a call for the global scientific community to join — aims to unlock predictive models of the human cell to accelerate the cure and prevention of all disease. News April 29, 2026 [H2] Axios Exclusive: Zuckerberg-backed Biohub bets $500M on AI biology Press April 29, 2026 [H2] Time: If AI Can Model Cells, Science Can Deliver Cures Press April 3, 2026 [H2] Chronicle of Philanthropy: How Small Grants Can Bridge a Gap — and Lead to Big Changes Press April 2, 2026 [H2] Inside Philanthropy: CZI Is Poised to Become the World’s Largest Private Biomedical Funder. What Might That Look Like? Press April 1, 2026 [H2] New Biohub Investigators Will Engineer Immune-Cell ‘Scouts’ to Detect Disease at Earliest Stages News March 19, 2026 [H2] Inside Philanthropy: New Gene Therapy Trial Moves Forward Thanks to Chan Zuckerberg Initiative Press March 16, 2026 [H2] The Scientist: Three amino acids improve lipid nanoparticle therapy delivery to cells Press March 11, 2026 [H2] Simple ‘Cocktail’ of Amino Acids Dramatically Boosts Power of Anti-Inflammatory mRNA Therapies and CRISPR Gene Editing Adding three common amino acids to lipid nanoparticle injections increased mRNA delivery up to 20-fold, pushed gene editing efficiency to nearly 90%, and suppressed inflammation in a model of acute liver disease. News March 5, 2026 [H2] New tool reveals how T cell responses evolve across organs By tracking recently activated T cells over time and across tissues, researchers uncover immune dynamics that may inform future therapies for infection, cancer, and autoimmunity Blog
2979 chars
SUB-PAGE (https://biohub.org/ai-models/) AI models for biology research – Biohub
[H1] AI Models We develop frontier AI models, trained on large-scale biological datasets to understand and model life from the level of molecules to tissue and cells. [H2] ESM Cambrian A next generation language model trained on protein sequences at the scale of life on Earth. ESMC defines a new state of the art for protein representation learning. Explore ESMC [H2] ESM3 A generative, multi-modal model that reasons over protein sequence, structure, and function. ESM3 enables programmable generation of proteins. Explore ESM3 [H2] Data We generate large-scale biological data that spans model systems and organisms, experimental and observational methods, and diverse cellular states and make these data openly available to help scientists accelerate discoveries. [IMG: CELL×GENE dataset] [H3] CELL×GENE An interactive data explorer for single-cell datasets that leverages modern web development techniques to enable fast visualizations of at least 1 million cells, enabling data exploration. Learn More [H3] CryoET Data Portal A cloud-based, open-source portal aimed at driving the development of automated annotations of cryoET datasets and shortening data processing time from months or years to weeks. Learn More [H2] A coordinated global effort for scaling biological data to build a predictive model of life Biohub’s Virtual Biology Initiative is a shared global effort to generate the data that is critical for building artificial intelligence models for cellular biology and unlocking new scientific insights. This initiative is the next step in Biohub’s decade-long effort to advance technologies to measure cells across scales and contexts, and to accelerate the scientific understanding of cellular biology to cure or prevent disease, including its support of large-scale data generation projects such as the Human Cell Atlas, the Billion Cells Project, and the Tabula Sapiens multi-organ cell atlas, and a range of integrated grant programs across imaging and instrumentation, spatial molecular biology, and synthetic biology. Learn more
2054 chars
SUB-PAGE (https://biohub.org/research/) Scientific research publications – Biohub
[H1] Research We believe in sharing the research findings of our teams and partners openly to accelerate understanding of human health and disease. We strongly encourage researchers to deposit manuscripts as preprints before peer review to increase access to research findings and to communicate results more quickly. Since 2015, we have supported more than 8,000 publications. Filter 84 Results [H2] Filter Close March 11, 2026 [H2] Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle-mediated mRNA delivery in preclinical models Kangfu Chen, Wenhan Wang, Amber Lennon, et al. (2026) | Science Translational Medicine Read more March 5, 2026 [H2] Tissue-specific clonal selection and differentiation of CD4⁺ T cells during infection Roham Parsa, Arpita Sushil (2026) | Nature Immunology Read more February 28, 2026 [H2] AI-Guided CRISPR Screen Accelerates Discovery of New Drug Targets Mushaine Shih, Amber Lennon, Jason Perera, et al. (2026) | bioRxiv Read more February 9, 2026 [H2] Virtual Cells Need Context, Not Just Scale Payam Dibaeinia, Sudarshan Babu, Mei Knudson, et al. (2026) | bioRxiv Read more February 9, 2026 [H2] DecoderTCR: Compositional Pretraining and Entropy-Guided Decoding for TCR-pMHC Interactions Ben Lai, Melissa Englund, Ramit Bharanikumar, et al. (2026) | bioRxiv Read more November 4, 2025 [H2] Scalable Single-Cell Gene Expression Generation with Latent Diffusion Models Giovanni Palla, Sudarshan Babu, Payam Dibaeinia, et al. (2025) | arXiv Read more November 2, 2025 [H2] VariantFormer: A hierarchical transformer integrating DNA sequences with genetic variations and regulatory landscapes for personalized gene expression prediction Sayan Ghosal, Youssef Barhomi, Tejaswini Ganapathi, et al. (2025) | bioRxiv Read more October 10, 2025 [H2] A path towards AI-scale, interoperable biological data Brian Aevermann, Andrea Califano, Chi-Li Chiu, et al. (2025) | arXiv Read more August 28, 2025 [H2] Tissue-specific clonal selection and differentiation of CD4⁺ T cells during infection Roham Parsa, Helder Assis, Tiago B.R. de Castro, et al. (2025) | bioRxiv Read more August 22, 2025 [H2] rbio1-training scientific reasoning LLMs with biological world models as soft verifiers Ana-Maria Istrate, Fausto Milletari, Fabrizio Castrotorres, et al. (2025) | bioRxiv Read more July 9, 2025 [H2] GREmLN: A Cellular Regulatory Network-Aware Transcriptomics Foundation Model Mingxuan Zhang, Vinay Swamy, Rowan Cassius, et al. (2025) | bioRxiv Read more May 23, 2025 [H2] Variational Control for Guidance in Diffusion Models Kushagra Pandey, Farrin Marouf Sofian, Felix Draxler, et al. (2025) | ICML 2025 Read more
3102 chars
🧭 Industry Context — common generic-claim patterns in Science, Research & Laboratories to weigh the text against
Generic Claims:
world-class research, pioneering scientific breakthroughs, advancing knowledge, trusted by leading institutions, cutting-edge laboratory, precision and accuracy…
Red Flags:
accreditation claims without certificate numbers, no publication record for research claims, unnamed scientists or researchers, breakthrough claims without peer review, laboratory photos that are stock images, quality claims without accrediting body…
Semantic Drift Patterns:
homepage claims cutting-edge but equipment list is dated, claims accredited but no accreditation schedule or scope shown, research claims but no publication list, claims GLP but no regulatory inspection history…
Proof Expectations:
accreditation certificate numbers and scope (ISO 17025, GLP), publication list with peer-reviewed journal citations, named principal investigators with verifiable track records, specific equipment list with calibration status, quality management documentation, regulatory inspection history and compliance…
Explore the other reputation pillars for Biohub
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from Biohub, captured on May 26, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Biohub: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://biohub.org to view the most current version of its content and see directly what this company is about and what it offers.